AN1 — Anagenics Cashflow Statement
0.000.00%
Last trade - 00:00Consumer DefensivesHighly SpeculativeMicro Cap
Annual cashflow statement for Anagenics, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | 1.01 | 0.932 | 0.651 | 0.368 | 0.639 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -4.01 | -4.11 | -2.53 | -1.76 | -1.74 |
| Capital Expenditures | 0 | -0.022 | -0.036 | -0.045 | -0.098 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | 0.5 | -0.932 | -1.46 | -0.1 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0 | 0.478 | -0.968 | -1.51 | -0.198 |
| Financing Cash Flow Items | -0.607 | -0.434 | -0.024 | -0.293 | -0.178 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 7.98 | 3.5 | 0.073 | 2.54 | 0.994 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 3.89 | -0.243 | -3.44 | -0.718 | -0.943 |